thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34702964-11472B72-2A60-46CF-B53B-628900A01AAA
Q34702964-11472B72-2A60-46CF-B53B-628900A01AAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34702964-11472B72-2A60-46CF-B53B-628900A01AAA
How can we manage resistance to antiangiogenic drugs?
P2860
Q34702964-11472B72-2A60-46CF-B53B-628900A01AAA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34702964-11472B72-2A60-46CF-B53B-628900A01AAA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
edd1ebf78de7bba8d8fdd060a0f6c631b28e9f5f
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.